Stay updated on LANRA + Gilteritinib in FLT3+ R/R AML Clinical Trial
Sign up to get notified when there's something new on the LANRA + Gilteritinib in FLT3+ R/R AML Clinical Trial page.

Latest updates to the LANRA + Gilteritinib in FLT3+ R/R AML Clinical Trial page
- Check3 days agoChange DetectedThe page history shows a new revision (v3.3.4) was added and the previous revision (v3.3.3) removed, which are backend metadata updates and do not modify the study details presented on the page. They reflect version control rather than substantive updates to the record. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedFooter updated to Revision: v3.3.3 and removal of HHS Vulnerability Disclosure; no core study information or functions were changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check54 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2 on the page, indicating a site UI revision. This change does not modify any study data or historical records.SummaryDifference0.1%

- Check61 days agoChange DetectedRemoved the footer notice about government funding and operating status. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check75 days agoChange DetectedNew entries have been added to the Record History, showing updated study status and recruitment information.SummaryDifference0.1%

- Check104 days agoChange Detected- Added a government operations notice and operating details, plus a new v3.2.0 revision. - Removed the previous v3.1.0 revision.SummaryDifference11%

Stay in the know with updates to LANRA + Gilteritinib in FLT3+ R/R AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LANRA + Gilteritinib in FLT3+ R/R AML Clinical Trial page.